BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Cardax Reports Q1 2018 Results

  - ZanthoSyn® Sales Nearly 3-Fold Higher Than Q1 2017 - ZanthoSyn® #1 In Hawaii GNC Stores For Two Quarters In A Row - Accelerating Sales Trend In California And Nevada

  May 9, 2018

   · 

  3 min read
• Policy

  Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

  Agreement gives groundbreaking human platelet company access to crucial technologies as it advances its program to manufacture human platelets at scale

  May 9, 2018

   · 

  2 min read
• Biotech Beach

  Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical Needs

  Strategic focus on unleashing therapeutic potential of specific orphan GPCRs, including novel family of Mas-Related G-Protein Receptors

  May 9, 2018

   · 

  5 min read
• Pharm Country

  LyGenesis Closes $3 Million Series A Financing to Advance Its Organ Regeneration Technology to the Clinic

  Groundbreaking technology regrows organs inside a patient’s own lymph nodes

  May 9, 2018

   · 

  4 min read
• BioCapital

  Five Things to Know About the 6.2 Billion-Dollar Biosimilar Business

  Kalorama Information estimates that the global market for biosimilar products has grown to be worth almost $6.2 billion by the end of the year, according to its new report, Biosimilars: Global Market, Trends and Competitor Analysis.

  May 9, 2018

   · 

  4 min read
• Business

  Arca Biopharma Announces First Quarter 2018 Financial Results and Provides Corporate Update

  ARCA biopharma, Inc. reported financial results for the quarter ended March 31, 2018.

  May 9, 2018

   · 

  7 min read
• Biotech Bay

  American Pharmaceutical Review Releases Documentary on Continuous Pharmaceutical Manufacturing

  American Pharmaceutical Review, the leading review of business and technology for the pharmaceutical industry throughout North America has released its documentary on “Continuous Pharmaceutical Manufacturing - Current Trends and Future Possibilities”

  May 9, 2018

   · 

  3 min read
• Business

  Ophthotech Reports First Quarter 2018 Financial and Operating Results

  Ophthotech is a science-driven biopharmaceutical company specializing in the development of novel therapies to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases

  May 9, 2018

   · 

  9 min read
• Business

  Mylan Reports First Quarter 2018 Results and Reaffirms 2018 Guidance

  Total revenues of $2.68 billion, down 1% compared to the prior year period.

  May 9, 2018

   · 

  61 min read
• Business

  Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders

  Provention acquires PRV-031 and plans to initiate pivotal Phase 3 clinical trial to intercept early-onset type 1 diabetes, a pediatric orphan indication

  May 9, 2018

   · 

  7 min read